Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Affiliations

Science Blogs
ACI Profile for Alan Kotok
Featured in Alltop

Smartphone-Controlled Cells Produce Insulin on Demand

A system designed by researchers in China and Switzerland and controlled by a smartphone app was shown in lab mice to produce insulin on demand from engineered pancreas cells. . . . → Read More: Smartphone-Controlled Cells Produce Insulin on Demand

Grid Computing Harnessed for Childhood Cancer Research

An international consortium is seeking crowdsourced computing power to screen drug candidates for treating a number of cancers affecting children. . . . → Read More: Grid Computing Harnessed for Childhood Cancer Research

Pharma Firms Start Non-Communicable Disease Initiative

A group of 22 pharmaceutical companies is supporting worldwide projects to improve access to prevention and treatments for chronic disorders like cancer and heart disease, in lower-resource regions. . . . → Read More: Pharma Firms Start Non-Communicable Disease Initiative

Precision Health Tech Network Expands, Invests $400M

Digital Life Alliance, a consortium of enterprises applying advanced technologies to health and medicine that plans to offer personalized solutions, is expanding to 7 members, as well as iCarbonX, the company that founded the network. . . . → Read More: Precision Health Tech Network Expands, Invests $400M

Biotech, Pharma Partner on Neuro Drug Discovery

A collaboration between a biotechnology enterprise tracking defective proteins and pharmaceutical company plans to discover new treatments for neurodegenerative disorders. . . . → Read More: Biotech, Pharma Partner on Neuro Drug Discovery

Ostrich Antibodies to Fight Resistant Infections

A biotechnology company developing antibodies grown in ostrich eggs is partnering with a Boston hospital to test a new treatment for Clostridium difficile, or C. difficile, a stubborn infection, increasingly resistant to antibiotics, and often contracted in hospitals. . . . → Read More: Ostrich Antibodies to Fight Resistant Infections

Liquid Biopsy Lab to Reside at Cancer Institute

A designer of liquid biopsy tests to diagnose cancer is establishing a lab to study circulating tumor cells at John Wayne Cancer Institute in Santa Monica, California. . . . → Read More: Liquid Biopsy Lab to Reside at Cancer Institute

Teva Licenses Pain Relief Antibody for $1.25 Billion

Teva Pharmaceutical Industries is licensing from biotechnology company Regeneron Pharmaceuticals an engineered antibody that targets proteins supporting pain signals. . . . → Read More: Teva Licenses Pain Relief Antibody for $1.25 Billion

Takeda Awarded $19.8 Million for Zika Vaccine

Takeda Pharmaceutical Company is receiving $19.8 million from a U.S. public health agency for initial steps to develop a vaccine to prevent Zika infections. . . . → Read More: Takeda Awarded $19.8 Million for Zika Vaccine

$1 Million Challenge Seeks Child Health Solutions

A new challenge seeks technologies and solutions to reduce child mortality and improve the health of children in low-resource regions of the world. . . . → Read More: $1 Million Challenge Seeks Child Health Solutions